Literature DB >> 12479505

Efficacy of topical phenol decontamination strategies on severity of acute phenol chemical burns and dermal absorption: in vitro and in vivo studies in pig skin.

N A Monteiro-Riviere1, A O Inman, H Jackson, B Dunn, S Dimond.   

Abstract

Pure phenol is colorless and used in the manufacture of phenolic resins, plastics, explosives, fertilizers, paints, rubber, textiles, adhesives, pharmaceuticals, paper, soap, and wood preservatives. The purpose of this study was to compare the efficacy of several phenol decontamination strategies following dermal exposure using the pig as a model for human exposure, and then assess the effect of the two best treatments on phenol absorption in the isolated perfused porcine skin flap (IPPSF). Six anesthetized Yorkshire pigs were exposed to 89% aqueous phenol for 1 min using Hilltop chambers (10 skin sites/pig; 400 microl/site). Exposure to phenol was followed by one of 10 different decontamination procedures: 1-, 5-, 15-, and 30-min water wash; Ivory soap solution; polyethylene glycol (PEG 400); PEG 400/industrial methylated spirits (IMS); PEG 400/ethanol (EtOH); polyvinyl pyrrolidone (PVP)/70% isopropanol (IPA); and 70% IPA. For each of the last five strategies, 1-min treatment washes were repeatedly alternated with 1-min water washes for a total of 15 min. Evaluation was based on scoring of erythema, edema, and histological parameters such as intracellular and intercellular epidermal edema, papillary dermal edema, perivascular infiltrates, pyknotic stratum basale cells, and epidermal-dermal separation. It was concluded that PEG 400 and 70% IPA were superior to the other treatments investigated and equally efficacious in the reduction of phenol-induced skin damage. In addition, phenol absorption was assessed utilizing the two most effective in vivo treatments in the IPPSF. The assessment of percutaneous absorption of phenol found the PEG 400, 70% IPA, and 15-min water treatments significantly (P < 0.05) reduced phenol absorption relative to no treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12479505     DOI: 10.1191/0748233701th095oa

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  5 in total

Review 1.  Use of Polyphenolic Compounds in Dermatologic Oncology.

Authors:  Adilson Costa; Michael Yi Bonner; Jack L Arbiser
Journal:  Am J Clin Dermatol       Date:  2016-08       Impact factor: 7.403

2.  Phenol Toxicity Following Cutaneous Exposure to Creolin®: A Case Report.

Authors:  David Vearrier; Dorian Jacobs; Michael I Greenberg
Journal:  J Med Toxicol       Date:  2015-06

3.  Evidence-based patient decontamination: an integral component of mass exposure chemical incident planning and response.

Authors:  Adam D Leary; Michael D Schwartz; Mark A Kirk; Joselito S Ignacio; Elaine B Wencil; Susan M Cibulsky
Journal:  Disaster Med Public Health Prep       Date:  2014-05-27       Impact factor: 5.556

4.  Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours.

Authors:  Suzan Hm Verdegaal; Jan den Hartigh; Pancras Cw Hogendoorn; Hugo Fg Brouwers; Antonie Hm Taminiau
Journal:  Clin Sarcoma Res       Date:  2012-03-26

Review 5.  Finding possible pharmacological effects of identified organic compounds in medicinal waters (BTEX and phenolic compounds).

Authors:  István Szabó; Csaba Varga
Journal:  Int J Biometeorol       Date:  2019-10-31       Impact factor: 3.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.